Form 8-K - Current report:
SEC Accession No. 0000950123-10-022940
Filing Date
2010-03-10
Accepted
2010-03-10 13:02:29
Documents
1
Period of Report
2010-03-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c97575e8vk.htm 8-K 7577
  Complete submission text file 0000950123-10-022940.txt   9114
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 10669744
SIC: 2835 In Vitro & In Vivo Diagnostic Substances